Decera Clinical Education Oncology Podcast
Episodes
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States
01 Feb 2021
Contributed by Lukas
In this episode, Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma info...
An Expert Overview of Immunotherapy for Advanced HCC
19 Jan 2021
Contributed by Lukas
Link to CME: Claim CreditIn this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations in the contemporary use of immune...
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain
08 Jan 2021
Contributed by Lukas
In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in t...
Expert Answers to Pathologist Questions on New Biomarkers for Precision Therapy in Lung Cance
28 Dec 2020
Contributed by Lukas
In this episode, Nathan Pennell, MD, PhD, and Laura J. Tafe, MD, provide medical oncology and pathology perspectives, respectively, when answering que...
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ
24 Dec 2020
Contributed by Lukas
In this episode,William G. Wierda, MD, PhD, Jeremy S. Abramson, MD, MMSc, and Brian Hill, MD, PhD, answer questions focused on personalizing therapy f...
Practical Insights on Key Data From ESMO 2020 Informing Precision Medicine in NSCLC
21 Dec 2020
Contributed by Lukas
In this episode, Helena A. Yu, MD, and Maria E. Arcila, MD, provide medical oncology and pathology perspectives, respectively, on new data from ESMO 2...
Immunotherapy for Advanced HCC: Experts Answer Clinician Questions
17 Dec 2020
Contributed by Lukas
Link to CME: Claim CreditIn this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer clinician questions on current best practices and emerg...
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom
20 Nov 2020
Contributed by Lukas
In this episode, Thomas Powles, MBBS, MRCP, MD, and Michiel van der Heijden, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial ...
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
19 Nov 2020
Contributed by Lukas
In this episode, Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest immuno-oncology developments in the treatment o...
Molecular Classification of Endometrial Carcinoma in the Clinic Today
11 Nov 2020
Contributed by Lukas
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of molecular testing and clas...
Advances in Immunotherapy for Endometrial Cancer
11 Nov 2020
Contributed by Lukas
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of immunotherapy for the trea...
Developments in Acute Leukemias: Expert Answers to Clinician Questions
02 Oct 2020
Contributed by Lukas
In this episode, David Marks, MD, PhD, and Stéphane de Botton, MD, answer questions from clinicians on management pearls for patients with acute leuk...
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
02 Oct 2020
Contributed by Lukas
In this episode, Isabelle Ray Coquard, MD, PhD and Bradley J. Monk, MD, FACS, FACOG, discuss current first-line maintenance therapy options for patien...
Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond
02 Oct 2020
Contributed by Lukas
Listen to Prof Nicoletta Colombo and Bradley J. Monk, MD, FACS, FACOG, discuss current best practices for biomarker testing for your patients with adv...
Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC
21 Sep 2020
Contributed by Lukas
In this podcast episode, listen to breast cancer experts Thomas Bachelot, MD, PhD; Adam M. Brufsky, MD, PhD; and Cristina Saura, MD, PhD, discuss clin...
The Art of Medicine: Clinical Considerations for Patients With Advanced RCC
21 Sep 2020
Contributed by Lukas
In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses c...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
17 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer questions focused on the optimizing BTK inhibitor thera...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
17 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optima...
Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC
17 Sep 2020
Contributed by Lukas
In this podcast episode, listen to lung cancer experts Joshua Bauml, MD, a medical oncologist, and Dara L. Aisner, MD, PhD, a molecular pathologist, d...
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
16 Sep 2020
Contributed by Lukas
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optim...
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions
14 Sep 2020
Contributed by Lukas
In this episode, Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer clinician questions on current best practices and em...
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond
08 Sep 2020
Contributed by Lukas
In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses curr...
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
03 Sep 2020
Contributed by Lukas
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current ...
New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
01 Sep 2020
Contributed by Lukas
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regar...
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
31 Aug 2020
Contributed by Lukas
In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treatm...
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
31 Aug 2020
Contributed by Lukas
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle c...
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1
28 Aug 2020
Contributed by Lukas
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on MET exon 14 testing and sele...
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2
28 Aug 2020
Contributed by Lukas
In this episode, Luis Paz-Ares, MD, PhD; D. Ross Camidge, MD, PhD; and Karen L. Reckamp, MD, MS, address questions on biomarking testing and the use ...
Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
27 Aug 2020
Contributed by Lukas
In this episode, Anna F. Farago, MD, PhD, and Taofeek K. Owonikoko, MD, PhD, answer questions focused on the topic of current and evolving use of im...
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL
26 Aug 2020
Contributed by Lukas
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in CLL presented at the 2020 annual meeting...
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
14 Aug 2020
Contributed by Lukas
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly ...
Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions
14 Aug 2020
Contributed by Lukas
In this episode, George D. Demetri, MD; Alexander Drilon, MD; and Pashtoon Kasi, MD, answer questions about NTRK fusion testing and TRK inhibitor ther...
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast
13 Aug 2020
Contributed by Lukas
In this episode, Prof. Dr. med Tim Henrik Brümmendorf; Jorge Cortes, MD; and Carlo Gambacorti-Passerini, MD, answer questions focused on the optimal...
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
10 Aug 2020
Contributed by Lukas
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therap...
Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions
10 Aug 2020
Contributed by Lukas
In this episode, an expert medical oncology panel led by John L. Marshall, MD, with Jamie E. Chaft, MD, and Scot Niglio, MD, provides a brief overvie...
Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
10 Aug 2020
Contributed by Lukas
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on current and evolving biomarkers for immune chec...